These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7578329)

  • 41. Emulsions of perfluorinated solvents for intravascular gas transport.
    Clark LC; Wesseler EP; Kaplan S; Miller ML; Becker C; Emory C; Stanley L; Becattini F; Obrock V
    Fed Proc; 1975 May; 34(6):1468-77. PubMed ID: 1126444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term observation of PFC storage in organs of rats after various dosages.
    Pfannkuch F; Schnoy N
    Prog Clin Biol Res; 1983; 122():209-19. PubMed ID: 6878363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood.
    Shah N; Mehra A
    ASAIO J; 1996; 42(3):181-9. PubMed ID: 8725685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retrieval of artificial blood cells (perfluorochemical) from whole blood.
    Agishi T; Takayama H; Teraoka S; Yamagata K; Kobayashi M; Ota K
    Trans Am Soc Artif Intern Organs; 1983; 29():456-9. PubMed ID: 6673267
    [No Abstract]   [Full Text] [Related]  

  • 45. Rheology of concentrated perfluorocarbon emulsions.
    Ni Y; Klein DH; Pelura TJ
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):869-71. PubMed ID: 1391526
    [No Abstract]   [Full Text] [Related]  

  • 46. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
    Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experimental research on the use of fluorocarbon compounds (FC 43) as blood substitutes].
    Motta G; Ratto GB; Spinelli E; Burlando F; Agati R; Poloniato G; Sacco A; Leonardi M
    Boll Soc Ital Biol Sper; 1981 Dec; 57(24):2529-35. PubMed ID: 7337765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fluorocarbons as possible oxygen-carrying blood substitutes].
    Afonin NI; Doronina NN
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):41-5. PubMed ID: 7220520
    [No Abstract]   [Full Text] [Related]  

  • 49. [Influence of Perftoran nanoemulsion on blood plasma concentrations of lipophilic drugs].
    Pshenkina NN
    Eksp Klin Farmakol; 2012; 75(2):30-4. PubMed ID: 22550857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of perfluorocarbon blood substitutes in tissues using F-19 magnetic resonance spectroscopy.
    Pratt RG; Thomas SR; Millard RW; Samaratunga RC; Naseem MH
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):921-4. PubMed ID: 1391534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aerobic preservation of organs using a new perflubron/lecithin emulsion stabilized by molecular dowels.
    Voiglio EJ; Zarif L; Gorry FC; Krafft MP; Margonari J; Martin X; Riess J; Dubernard JM
    J Surg Res; 1996 Jul; 63(2):439-46. PubMed ID: 8661239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emulsified perfluorochemicals as respiratory gas carriers: recovery of perfluorodecalin emulsion droplets from rat tissues.
    Lowe KC; Washington C
    J Pharm Pharmacol; 1993 Nov; 45(11):938-41. PubMed ID: 7908032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations of liver and spleen following intravenous infusion of fluorocarbon emulsions.
    Rosenblum WI; Hadfield MG; Martinez AJ; Schatzki P
    Arch Pathol Lab Med; 1976 Apr; 100(4):213-7. PubMed ID: 989286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influence of a fluorocarbon blood substitute on phagocytic function of the liver and spleen].
    Ding XC; Zhang SN; Liu CF; Wang GF; Wang BS
    Zhongguo Yao Li Xue Bao; 1983 Sep; 4(3):180-3. PubMed ID: 6228117
    [No Abstract]   [Full Text] [Related]  

  • 55. One-year observation of Wistar rats after intravenous infusion of hemoglobin-vesicles (artificial oxygen carriers).
    Sakai H; Tsuchida E; Horinouchi H; Kobayashi K
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):81-91. PubMed ID: 17364473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidative damages in the DNA, lipids, and proteins of rats exposed to isofluranes and alcohols.
    Kim H; Oh E; Im H; Mun J; Yang M; Khim JY; Lee E; Lim SH; Kong MH; Lee M; Sul D
    Toxicology; 2006 Mar; 220(2-3):169-78. PubMed ID: 16442689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Sorption of plasma components on the surface of particles of fluorocarbon emulsions stabilized by proxanol 268].
    Sklifas AN; Shekhtman DG; Evdokimov VA; Temnov AA; Antashov AV; Kaptsov VV; Ponomarchuk VV; Vorob'ev SI; Kukushkin NI
    Biofizika; 2002; 47(5):926-32. PubMed ID: 12397968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Terminal sterilization of perfluorocarbon (PFC) emulsions: difficulties and possible solutions.
    Dalfors JL; Espinosa CA
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):853-7. PubMed ID: 1391523
    [No Abstract]   [Full Text] [Related]  

  • 59. Biodistribution and excretion of a mixed fluorocarbon-hydrocarbon "dowel" emulsion as determined by 19F NMR.
    Zarif L; Postel M; Trevino L; Riess JG; Valla A; Follana R
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1193-8. PubMed ID: 7849922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Perfluorocarbon emulsions and other corpuscular systems influence on neutrophil activity].
    Shekhtman DG; Safronova VG; Sklifas AN; Alovskaia AA; Gapeev AB; Obraztsov VV; Chemeris NK
    Biofizika; 1997; 42(6):1260-6. PubMed ID: 9490112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.